1. Immunic, Inc.

    0 Comments Leave a Comment

    1-2 of 2
    1. Mentioned In 2 Articles

    2. Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips

      Immunic, Inc. Expands Board of Directors with Appointment of Biotechnology Executive Barclay A. Phillips
      Immunic, Inc. (IMUX),a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment of Barclay "Buck" A.Phillips, an established life sciences executive, investor and entrepreneur, to its Board of Directors, effectiveNovember 14, 2019...
      Read Full Article
    3. Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson

      Immunic, Inc. Expands Board of Directors with Appointment of Industry Veteran Tamar Howson
      SAN DIEGO,Oct. 15, 2019/PRNewswire/ --Immunic, Inc. (Nasdaq:IMUX),a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced the appointment ofTamar Howson, a highly seasoned life sciences executive, to its Board of Directors...
      Read Full Article
    4. 1-2 of 2
  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, In the News, Partner Publications, Sponsored Content